Trimetazidine Dihydrochloride
Trimetazidine Dihydrochloride
Trimetazidine Dihydrochloride is a 3-ketoacyl-coenzyme, a thiolase inhibitor. It is a cellular antiischemic agent indicated in the management and prophylaxis of angina pectoris.
Online Inquiry
| CAT# | 10-101-126 |
| CAS | 5011-34-7 (net), 13171-25-0 (dihydrochloride) |
| Synonyms/Alias | 1-(2,3,4-Trimethoxybenzyl)piperazine · 2 HCl |
| M.F/Formula | C14H24N2O3 |
| M.W/Mr. | 268.35 |
| Labeling Target | 3-ketoacyl-CoA thiolase, peroxisomal |
| Application | Trimetazidine is an anti-ischemic (anti-anginal) metabolic agent, which improves myocardial glucose utilization through inhibition of fatty acid metabolism, also known as fatty acid oxidation inhibitor. |
| Activity | Inhibitor |
| Biological Activity | Trimetazidine dihydrochloride is a kind of drug for treatment of chronic ischemic disorders. It improves myocardial glucose utilization through inhibition of fatty acid metabolism, known as fatty acid oxidation inhibitor. |
| Areas of Interest | Cardiovascular Disease |
| Functions | Palmitoyl-coa oxidase activity |
| Disease | Angina pectoris |
| Target | Fatty Acid Oxidation |
| Source# | Synthetic |
Organism | Human |
Write a review
Ask a question
My Review for Trimetazidine Dihydrochloride
Required fields are marked with *
×
Ask a Question for Trimetazidine Dihydrochloride
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
